Consequences of obstructive sleep apnoea

被引:0
作者
Gurubhagavatula, Indira [1 ,2 ,3 ]
机构
[1] Univ Penn, Med Ctr, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Div Sleep Med, Philadelphia, PA 19104 USA
[3] Philadelphia VA Med Ctr, Pulm & Crit Care & Sleep Sect, Philadelphia, PA USA
关键词
Day time sleepiness; health care cost; obstructive sleep apnoea; quality of life; traffic accidents; vigilence; HEALTH-CARE UTILIZATION; QUALITY-OF-LIFE; LATENCY TEST MSLT; AUTOMOBILE ACCIDENTS; COMMERCIAL DRIVERS; DAYTIME SLEEPINESS; COGNITIVE FUNCTION; ASSOCIATION; PERFORMANCE; RISK;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A plethora of medical consequences have been associated with the syndrome of obstructive sleep apnoea (OSA). These are global, affecting nearly every body function, and have been related to two key pathophysiological findings in sleep apnoea: repetitive falls in oxyhaemoglobin saturation during sleep, and recurrent arousals from sleep which terminate apnoea episodes. Sufferers of OSA may experience daytime sleepiness, which has been measured both subjectively using the Epworth Sleepiness Scale and the Stanford Sleepiness Scale, but also objectively, using Multiple Sleep Latency Testing, Maintenance of Wakefulness testing, and the Oxford Sleep Resistance test. In addition to the loss of alertness, sleep apnoea contributes to memory deficits, reduced vigilance, impaired executive function, increased risk for automobile and occupational accidents, and decreased quality of life. Importantly, afflicted individuals experience improvements in these outcomes with treatment. Taken together, this evidence forms a compelling basis to identify and treat latent cases of sleep apnoea. Not only do patients have the opportunity to achieve improvements in these outcomes and health-related quality of life, but the enormous economic burden that untreated apnoea imposes on the health care system may be eased.
引用
收藏
页码:188 / 195
页数:8
相关论文
共 49 条
  • [41] Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome
    Sassani, A
    Findley, LJ
    Kryger, M
    Goldlust, E
    George, C
    Davidson, TM
    [J]. SLEEP, 2004, 27 (03) : 453 - 458
  • [42] Determinants of altered quality of life in patients with sleep-related breathing disorders
    Sforza, E
    Janssens, JP
    Rochat, T
    Ibanez, V
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (04) : 682 - 687
  • [43] Multiple Sleep Latency Test and Maintenance of Wakefulness Test
    Sullivan, Shannon S.
    Kushida, Clete A.
    [J]. CHEST, 2008, 134 (04) : 854 - 861
  • [44] Determinants affecting health-care utilization in obstructive sleep apnea syndrome patients
    Tarasiuk, A
    Greenberg-Dotan, S
    Brin, YS
    Simon, T
    Tal, A
    Reuveni, H
    [J]. CHEST, 2005, 128 (03) : 1310 - 1314
  • [45] Defining association between sleep apnea syndrome and erectile dysfunction
    Teloken, Patrick E.
    Smith, Eric B.
    Lodowsky, Chris
    Freedom, Thomas
    Mulhall, John P.
    [J]. UROLOGY, 2006, 67 (05) : 1033 - 1037
  • [46] The association between sleep apnea and the risk of traffic accidents
    Terán-Santos, J
    Jiménez-Gómez, A
    Cordero-Guevara, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (11) : 847 - 851
  • [47] Neurocognitive effects of obstructive sleep apnea syndrome
    Verstraeten, Edwin
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2007, 7 (02) : 161 - 166
  • [48] Weaver TE, 1997, SLEEP, V20, P835
  • [49] Health care costs and the sleep apnea syndrome
    Wittmann, V
    Rodenstein, DO
    [J]. SLEEP MEDICINE REVIEWS, 2004, 8 (04) : 269 - 279